<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04907318</url>
  </required_header>
  <id_info>
    <org_study_id>PHY PODT-POD FT</org_study_id>
    <nct_id>NCT04907318</nct_id>
  </id_info>
  <brief_title>Comparison Between a Toric Monofocal and Multifocal Intraocular Lens</brief_title>
  <official_title>Retrospective Study Analysing the Results of Toric and Toric Multifocal Intraocular Lens Implantation During Cataract Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beaver-Visitec International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beaver-Visitec International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to observe the rotational stability of the implant 30&#xD;
      minutes, one day, 6 weeks, 6 months and 12 months after the implant surgery. In addition, the&#xD;
      refraction will be measured as it is directly affected in the event of postoperative&#xD;
      rotation. The correlation between postoperative rotation and the following parameters will be&#xD;
      determined: PEXS, white-to-white, age, axial length, anterior chamber depth. Visual acuities&#xD;
      with and without correction and the best refraction to assess the benefit of the implants&#xD;
      will also be investigated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This retrospective study will include approximately 90 eyes of patients (adults) receiving&#xD;
      conventional cataract surgery having a preoperative corneal astigmatism of 1.0 D or higher.&#xD;
      They had been implanted with the Ankoris or T-Flex or FineVision toric implant (about 30/30&#xD;
      and20). So that the groups are comparable, the inclusion and exclusion criteria will be those&#xD;
      applicable to a multifocal implant.&#xD;
&#xD;
      Inclusion criteria for research participants.&#xD;
&#xD;
        -  Cataract (with or without presbyopia)&#xD;
&#xD;
        -  No pre-existing ocular pathology or history of ocular surgery&#xD;
&#xD;
        -  No phacodonesis&#xD;
&#xD;
      PEX patients (pseudoexfoliation syndrome) can be included. Exclusion criteria for research&#xD;
      participants. To ensure equivalence of the two comparable groups, the patients with potential&#xD;
      postoperative visual acuity less than 5/10, particularly due to an insufficient retinal&#xD;
      function or poor corneal condition will be excluded.&#xD;
&#xD;
      In particular the patients with the following pathologies will be excluded:&#xD;
&#xD;
        -  Irregular astigmatism.&#xD;
&#xD;
        -  Cases of uncontrolled glaucoma.&#xD;
&#xD;
        -  Intraocular inflammation.&#xD;
&#xD;
        -  Narrow anterior chambers (2.5 mm).&#xD;
&#xD;
        -  Amblyopia with potential visual acuity less than 5/10.&#xD;
&#xD;
        -  Any corneal pathology potentially affecting topography (e.g., keratoconus).&#xD;
&#xD;
        -  Patients with a history of corneal surgery (especially refractive surgery).&#xD;
&#xD;
        -  Patients with diagnosed degenerative visual disorders (e.g., macular degeneration,&#xD;
           diabetic retinopathy or other retina diseases or surgery) with known negative impact on&#xD;
           visual function possibly leading to visual acuity levels below 0.5.&#xD;
&#xD;
        -  Patients with a history of ocular trauma.&#xD;
&#xD;
        -  Pathological miosis.&#xD;
&#xD;
        -  Patients with zonular laxity.&#xD;
&#xD;
        -  Patients suffering from chronic uveitis.&#xD;
&#xD;
        -  Patients with monophthalmia. Capsule rupture, intraocular haemorrhage, excessive loss of&#xD;
           vitreous, vitreous flare, soft capsules during cataract surgery are also exclusion&#xD;
           criteria.&#xD;
&#xD;
           3 - Adopted observation or investigation method This study involves the collection of&#xD;
           data in patient records that fall within the normal framework of cataract surgery.&#xD;
&#xD;
      The demographic and clinical data collected will be the yeat of birth and patient's gender,&#xD;
      including ocular or general comorbidities (such as diabetes or rheumatoid illnesses)&#xD;
      justifying the visual acuity performance.&#xD;
&#xD;
      The preoperative data collected will be: visual acuity, intraocular pressure, cell density of&#xD;
      the corneal endothelium, axial length and corneal power in both axes (data required to&#xD;
      routinely calculate the power of the implant and entered into the record to understand any&#xD;
      postoperative refractive errors).&#xD;
&#xD;
      The intraoperative data will be the power of the implant and any complications, if&#xD;
      applicable.&#xD;
&#xD;
      The postoperative data will be data collected during the standard postoperative follow-up&#xD;
      performed at 30 minutes, 1 day, one week, 6 weeks, 6 months and 1 year, with patient&#xD;
      questioning, slit lamp observation with implant position, measuring intraocular pressure,&#xD;
      determining the best refraction and measuring visual acuity with and without correction&#xD;
      (near, far and intermediate vision).&#xD;
&#xD;
      4 - Origin and nature of collected personal data Reason for using this data Observations will&#xD;
      be obtained by the doctor from patient records. Clinical data will be used to link potential&#xD;
      poor postoperative visual acuity and a comorbidity.&#xD;
&#xD;
      Refractive data will help determine the implant stability in the eye in terms of its depth,&#xD;
      i.e. in the sagittal plane, and its rotational stability, i.e. coronal plane stability.&#xD;
&#xD;
      Changes will determine its stability in the coronal plane around the visual axis.&#xD;
&#xD;
      The intraocular pressure analysis and slit lamp examination will help determine the eye&#xD;
      inflammatory status before and after surgery.&#xD;
&#xD;
      The record of postoperative keratometry values will help determine whether the error or a&#xD;
      refractive change caused by the corneal instability or by the change in the implant position.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">July 1, 2016</completion_date>
  <primary_completion_date type="Actual">June 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To observe the rotational stability of the implant</measure>
    <time_frame>6 Months</time_frame>
    <description>Observation of rotational stability of the implant</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>6 Months</time_frame>
    <description>To assess the visual acuities with and without correction and the best refraction to assess the benefit of the implants</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">60</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>ANKORIS</arm_group_label>
    <description>Cataract surgery performed with POD26PAYT</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FINEVISION TORIC</arm_group_label>
    <description>Cataract surgery performed with POD26PAYFT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cataract surgery</intervention_name>
    <arm_group_label>ANKORIS</arm_group_label>
    <arm_group_label>FINEVISION TORIC</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This retrospective study will include approximately 90 eyes of patients (adults) receiving&#xD;
        conventional cataract surgery having a preoperative corneal astigmatism of 1.0 D or higher&#xD;
        and had been implanted with the Ankoris or T-Flex or FineVision toric implant (about 30/30&#xD;
        and20). So that the groups are comparable, the inclusion and exclusion criteria will be&#xD;
        those applicable to a multifocal implant.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cataract (with or without presbyopia)&#xD;
&#xD;
          -  No pre-existing ocular pathology or history of ocular surgery&#xD;
&#xD;
          -  No phacodonesis&#xD;
&#xD;
        PEX patients (pseudoexfoliation syndrome) can be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        To ensure equivalence of the two comparable groups, the patients with potential&#xD;
        postoperative visual acuity less than 5/10, particularly due to an insufficient retinal&#xD;
        function or poor corneal condition will be excluded.&#xD;
&#xD;
        In particular the patients with the following pathologies will be excluded:&#xD;
&#xD;
          -  Irregular astigmatism.&#xD;
&#xD;
          -  Cases of uncontrolled glaucoma.&#xD;
&#xD;
          -  Intraocular inflammation.&#xD;
&#xD;
          -  Narrow anterior chambers (2.5 mm).&#xD;
&#xD;
          -  Amblyopia with potential visual acuity less than 5/10.&#xD;
&#xD;
          -  Any corneal pathology potentially affecting topography (e.g., keratoconus).&#xD;
&#xD;
          -  Patients with a history of corneal surgery (especially refractive surgery).&#xD;
&#xD;
          -  Patients with diagnosed degenerative visual disorders (e.g., macular degeneration,&#xD;
             diabetic retinopathy or other retina diseases or surgery) with known negative impact&#xD;
             on visual function possibly leading to visual acuity levels below 0.5.&#xD;
&#xD;
          -  Patients with a history of ocular trauma.&#xD;
&#xD;
          -  Pathological miosis.&#xD;
&#xD;
          -  Patients with zonular laxity.&#xD;
&#xD;
          -  Patients suffering from chronic uveitis.&#xD;
&#xD;
          -  Patients with monophthalmia. Capsule rupture, intraocular haemorrhage, excessive loss&#xD;
             of vitreous, vitreous flare, soft capsules during cataract surgery are also exclusion&#xD;
             criteria.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kristof Vandekerckhove, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vista Alpina Eye Cente, Visp, Switzerland, 3930</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vista Alpina Eye Center</name>
      <address>
        <city>Visp</city>
        <zip>3930</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 25, 2021</study_first_submitted>
  <study_first_submitted_qc>May 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>IOL</keyword>
  <keyword>Toric</keyword>
  <keyword>Multifocal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

